Background Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …

Purpose Weight gain is common among breast cancer patients and may contribute to poorer
treatment outcomes. Most programs target breast cancer survivors after the completion of …

Introduction Obesity is a known risk factor for postmenopausal breast cancer and is
associated with poorer prognosis for premenopausal and postmenopausal patients; …

Obesity adversely impacts overall and cancer‐specific survival among breast cancer
patients. Preclinical studies demonstrate negative energy balance inhibits cancer …

Numerous studies have demonstrated that a significant change in weight during
chemotherapy treatment was a factor of poor prognosis in early breast cancer women …

PURPOSE: Weight gain is a common problem among breast cancer patients who receive
adjuvant chemotherapy (CT). We undertook a study to determine the causes of this energy …

Weight gain is a commonly reported side effect of adjuvant chemotherapy. A change in
resting energy expenditure during treatment has been a suggested mechanism for weight …

Metabolic dysfunction and excess accumulation of adipose tissue are detrimental side
effects from breast cancer treatment. Diet and physical activity are important treatments for …

Background Obesity and weight gain have been associated with poor disease‐specific and
health‐related outcomes in women with breast cancer. Objectives This review aimed to …

PURPOSE Among breast cancer patients receiving adjuvant chemotherapy, weight gain is a
common side effect that may decrease quality of life and potentially threaten survival. Weight …